AngioDynamics Inc (ANGO)

17.86
NASDAQ : Health Care
Prev Close 17.83
Day Low/High 17.80 / 17.98
52 Wk Low/High 14.80 / 18.35
Avg Volume 201.90K
Exchange NASDAQ
Shares Outstanding 36.61M
Market Cap 652.70M
EPS 0.10
P/E Ratio 127.36
Div & Yield N.A. (N.A)

Latest News

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of AngioDynamics, Inc.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of AngioDynamics, Inc.

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against AngioDynamics, Inc.

ANGO: Insiders vs. Shorts

The most recent short interest data was recently released for the 06/30/2017 settlement date, and AngioDynamics Inc is one of the most shorted stocks of the Russell 3000, based on 6.90 "days to cover" versus the median component at 4.17. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

ANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation For Potential Securities Law Violations

ANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation For Potential Securities Law Violations

Girard Gibbs LLP is investigating potential claims on behalf of investors of AngioDynamics, Inc.

AngioDynamics Becomes Oversold (ANGO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Endo international, AngioDynamics Lead Biotech Movers

Endo international, AngioDynamics Lead Biotech Movers

Endo International slipped 5% ahead of market's open Friday.

ANGO Crosses Above Average Analyst Target

In recent trading, shares of AngioDynamics Inc have crossed above the average analyst 12-month target price of $17.40, changing hands for $17.58/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TheStreet Quant Rating: B- (Buy)